federal_register: 2023-03012

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2023-03012 Medications for the Treatment of Opioid Use Disorder: Removal of the DATA-2000 Waiver Requirements Proposed Rule The Department of Health and Human Services (HHS or "the Department") is issuing this supplemental notice of proposed rulemaking (SNPRM) to solicit public comment on its proposal to remove provisions authorized under the Controlled Substances Act (CSA), as amended by the Drug Addiction Treatment Act of 2000 (DATA-2000). These changes are as a result of amendments made in the Consolidated Appropriations Act, 2023, which was enacted on December 29, 2022. Among other things, section 1262(a)(1) of this Act amended the CSA by eliminating the requirement that practitioners obtain a waiver to prescribe certain schedule III-V medications for the treatment of opioid use disorder (OUD). 2023-02-13 2023 2 https://www.federalregister.gov/documents/2023/02/13/2023-03012/medications-for-the-treatment-of-opioid-use-disorder-removal-of-the-data-2000-waiver-requirements https://www.govinfo.gov/content/pkg/FR-2023-02-13/pdf/2023-03012.pdf Health and Human Services Department 221 The Department of Health and Human Services (HHS or "the Department") is issuing this supplemental notice of proposed rulemaking (SNPRM) to solicit public comment on its proposal to remove provisions authorized under the Controlled Substances Act... 0930-AA39

Links from other tables